|
Colorectal cancer Articles
Colorectal cancer News : Ontario will pay for colorectal cancer drug Thu, 03 Jul 2008 04:47:29 GMT New analyses of two randomized, controlled clinical trials investigating Erbitux (cetuximab) in the treatment of 1st-line metastatic colorectal cancer (mCRC) highlight the increased efficacy of Erbitux in patients with "normal," non-mutated or KRAS wild-type tumours.Colorectal cancer News : DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group Wed, 02 Jul 2008 11:10:29 GMT DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group Clarient Launches New Colorectal Cancer Test Tue, 01 Jul 2008 10:00:00 GMT Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced its new offering, KRAS, which has been validated as a laboratory-developed test to be used as a predictive molecular biomarker for patients with colorectal cancer .Jefferson doc's diagnostic test for colorectal cancer nears launch Mon, 30 Jun 2008 04:06:19 GMT DiagnoCure Inc., a Canadian life sciences company that has clinical laboratories in West Chester, is preparing to introduce a new diagnostic test for colorectal cancer in the United States this summer.DJ HUGIN NEWS/First Subjects Enrolled in Epigenomics sponsored PRESEPT Colorectal Cancer Screening Study Mon, 30 Jun 2008 07:28:10 GMT Multi-center study in U.S. and Germany enrolling up to 7,500 individuals aims at demonstrating the benefits of colorectal cancer population screening with Epigenomics' Septin 9 blood test Berlin, Germany, and Seattle, WA, USA, June 30, 2008 - Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer ...Lawmakers pass autism treatment, colorectal cancer screening, Blues merger bill Thu, 03 Jul 2008 16:11:11 GMT Pennsylvania legislators have finally agreed upon and passed a bill that advocates for people with autism say will make the state a national leader in helping children with autism.Colorectal cancer patients in Ontario to get test Thu, 03 Jul 2008 02:22:17 GMT Province had be paying for expensive cancer drug without providing screening tool that shows who wouldn't benefit DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group Wed, 02 Jul 2008 10:30:00 GMT DiagnoCure Inc. , a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced today that Dr. Timothy J. Holzer, Vice President, R&D and Production at DiagnoCure, and Dr.Poverty, Poor Health Might Influence Colorectal Cancer Screening Attendance Sat, 28 Jun 2008 08:15:02 GMT Patients who believe in the value of colorectal cancer screenings and fear cancer often say they would undergo preventive testing, but their intentions do not necessarily translate into action, according to a new study. "It's well known that people don't always do what they say they're going to do," said Emily Power, lead author.Avastin(R) Shows Unprecedented Benefits In Colorectal Cancer Patients, Irrespective Of K-Ras Gene Mutation Fri, 27 Jun 2008 12:15:52 GMT Data presented at the 10th World Congress on Gastrointestinal Cancer (WCGC) in Barcelona confirm that Avastin (bevacizumab) significantly improves survival in patients with metastatic colorectal cancer regardless of whether they have mutation in a gene known as K-Ras.Caplan details new cancer drug coverage Wed, 02 Jul 2008 23:57:08 GMT After months of lobbying by cancer patients who went into debt and fundraised so they could spend tens of thousands of dollars on an approved drug that could potentially save their lives, Health Minister David Caplan announced today that Ontario will now start paying for Avastin to treat colorectal cancer.Epigenomics initiates enrollment in colorectal cancer biomarker study Tue, 01 Jul 2008 02:43:43 GMT Germany based molecular diagnostics company Epigenomics has announced the enrollment of the first subjects in the Presept study.Wealth, health impact colon cancer screening Tue, 01 Jul 2008 18:26:09 GMT Good intentions don't always translate into action when it comes to colorectal cancer screening, researchers from the UK have found.Poverty, Poor Health Might Influence Colorectal Cancer Screening Attendance Fri, 27 Jun 2008 04:17:53 GMT Patients who believe in the value of colorectal cancer screenings and who fear cancer often say they would undergo preventive testing, but their intentions do not necessarily translate into action, according to a new study.Amgen reports positive results from colorectal cancer trial Fri, 27 Jun 2008 10:14:22 GMT Amgen has announced updated results from the Stepp trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer patients receiving epidermal growth factor receptor therapy.30.06.2008 - DJ HUGIN NEWS/First Subjects Enrolled in Epigenomics sponsored PRESEPT Colorectal Cancer Screening Study Mon, 30 Jun 2008 09:01:27 GMT Berlin, Germany, and Seattle, WA, USA, June 30, 2008 - Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced the enrollment of the first subjects in the PRESEPT study.ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial Of CoFactor(R) Wed, 02 Jul 2008 11:14:52 GMT ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU (5 fluorouracil), for the treatment of first-line metastatic colorectal cancer.MCOT English News : Artist with cancer to exhibit stunning artwork Wed, 02 Jul 2008 01:57:54 GMT A national aritist, who suffered from colorectal cancer, has been drawing an amazing collection of pictures with vivid color, which feature the power and energy of its creator.[ Home > Wed, 02 Jul 2008 12:54:06 GMT Are You Getting Enough Vitamin D? ] Are You Getting Enough Vitamin D? Vitamin D is important to the body because it helps to maintain bone density, aids in the absorption of calcium, and seems to lower the risk of certain cancers, such as breast, prostate, and colorectal cancer.First Subjects Enrolled in Epigenomics Sponsored PRESEPT Colorectal Cancer Screening Study Mon, 30 Jun 2008 07:07:56 GMT SEATTLE and BERLIN, June 30, 2008 -- Epigenomics AG , a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced the enrollment of the first subjects in the PRESEPT study.My Pharmiweb.com Tue, 01 Jul 2008 14:51:30 GMT Barcelona/Darmstadt, June 30, 2008 ââ¬â New analyses of two randomized, controlled clinical trials investigating Erbituxî (cetuximab) in the treatment of 1st-line metastatic colorectal cancer (mCRC) highlight the increased efficacy of Erbitux in patients with ââ¬Ånormal,ââ¬ï¿½ non-mutated or KRAS wild-type tumors.Takeda seeks approval for anti-cancer agent, panitumumab Tue, 01 Jul 2008 11:46:39 GMT Takeda Pharmaceutical Company Limited and Takeda Bio Development Center Limited (Takeda Bio) announced that they submitted a New Drug Application of anti-cancer agent, panitumumab (recombinant) (panitumumab) for the treatment of patients with progressed and/or relapse colorectal cancer to the Ministry of Health Labour and Welfare in Japan.Takeda files new drug application for anticancer drug Tue, 01 Jul 2008 02:44:22 GMT Takeda Pharmaceutical and Takeda Bio Development Center have submitted a new drug application of anti-cancer agent, panitumumab for the treatment of patients with progressed or relapse colorectal cancer to the Ministry of Health Labour and Welfare in Japan.ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) Tue, 01 Jul 2008 10:00:00 GMT ADVENTRX Pharmaceuticals, Inc. today announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU , for the treatment of first-line metastatic colorectal cancer.New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities In Patients Receiving Vectibix(R) ... Mon, 30 Jun 2008 10:14:32 GMT Amgen (NASDAQ: AMGN) announced updated results from the "STEPP" (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.My Pharmiweb.com Mon, 30 Jun 2008 07:51:39 GMT BARCELONA, Spain(BUSINESS WIRE)June 26, 2008Amgen (NASDAQ: AMGN) today announced updated results from the STEPP (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation Fri, 27 Jun 2008 02:34:49 GMT Ãù·Ãè 27 ÃöùÃù 2551 09:30 ¹.Bill moves on Pennsylvania autism insurance, Blues merger Fri, 04 Jul 2008 04:06:41 GMT HARRISBURG â Legislation providing for state oversight of proposed mergers of nonprofit health insurance companies received final legislative approval Wednesday and is headed to the governor for his signature and enactment into law.Avastin working for cancer patient Thu, 03 Jul 2008 10:24:30 GMT After a few months of treatment with Avastin, Kevin Bigford has a better chance to live a long, healthy life. "It's definitely improved because of the Avastin, my condition and prognosis," said the Port Colborne native who now lives in Kitchener. Bigford was diagnosed with stage 4 [...]WEBSTER GROVES: Relay for Life relates to cancer patients' ordeal Thu, 03 Jul 2008 05:51:07 GMT Kathy Kilkenny survived colon cancer and ovarian cancer.Fourth Annual Symposium On Liver-Directed Microsphere Therapy Raises Awareness Of The Latest Advances For Treating ... Thu, 03 Jul 2008 12:15:52 GMT More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy. The symposium, sponsored by the Goshen Center for Cancer Care, was supported by an educational grant provided by Sirtex Medical.Cancer drug funding good first step β Add your thoughts Thu, 03 Jul 2008 10:27:58 GMT It's a little victory, but it might not be enough. Thousands of cancer patients like Vera Patrick are spending their savings, pensions and food allowance to live longer lives. The two-time cancer survivor is happy the Ontario government announced Wednesday it's covering the bill for those who [...]Spice up your life Thu, 03 Jul 2008 17:10:19 GMT Medical breakthroughs could have everyone turning to spice racks and produce aisles instead of medicine cabinets to ward off illness.Group warns of grilling risks Thu, 03 Jul 2008 06:32:25 GMT Grilling may be as American as the Fourth of July, but what you put on your Weber and how you prepare it could affect your health.WEBSTER GROVES: Relay for Life relates to cancer patients' ordeal Thu, 03 Jul 2008 06:32:26 GMT By Jameka Merriweather Staff writer WEBSTER GROVES Kathy Kilkenny survived colon cancer and ovarian cancer.Targeted Therapies To Lead New Wave Of Breast Cancer Treatments Thu, 03 Jul 2008 12:13:22 GMT Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from Frost & Sullivan, U.S.Up to 1,500 to benefit from drug funding Thu, 03 Jul 2008 08:42:22 GMT Up to 1,500 Ontario cancer patients will be helped by the province's new infusion of $50 million toward expensive new drugs.ABRPL gets DBT approval for pre-clinical study of 3 bio-pharma products Thu, 03 Jul 2008 08:47:29 GMT Avesthagen Limited's subsidiary company Avesta Biotherapeutics & Research Private Limited (ABRPL) has received clearance from the Review Committee for Genetic Manipulation (RCGM) authorized by the Department of Biotechnology, Government of India to enter into a pivotal pre-clinical safety and efficacy evaluation study for three of its biopharmaceutical product development programmes.Ontario to spend $50M to cover costs of expensive cancer drugs Wed, 02 Jul 2008 15:58:00 GMT TORONTO - Health Minister David Caplan says the province will spend an additional $50 million to cover three of the most expensive cancer drugs.Cancer drug funding good first step Thu, 03 Jul 2008 05:43:08 GMT Itâs a little victory, but it might not be enough. Thousands of cancer patients like Vera Patrick are spending their savings, pensions and food allowance to live longer lives. The two-time cancer survivor is happy the Ontario government announced Wednesday itâs covering the bill for those who rely [...]Calendar Thu, 03 Jul 2008 07:28:10 GMT Events, screenings, support groups and more Programs Arthritis education Laurel Regional Hospital, 7300 Van Dusen Road, Laurel / Katherine Sperberg, health education coordinator for the Arthritis Foundation, D.C. Metro Chapter, will discuss what can be a disabling affliction at the Senior Dining and Lecture, 3 p.m.-5 p.m. Wednesday. $1 fee. To register, call 301-497-7914. Cancer group gives barbecue a grilling Thu, 03 Jul 2008 06:35:47 GMT Grilling may be as American as, well, the Fourth of July, but what you put on your Weber and how you prepare it could affect your health. So say experts at the American Institute for Cancer Research, which is urging people to substitute veggies for meat and change their grilling habits.Will Chemotherapy Work? Einstein Researchers Develop Test That May Offer Answer For Colorectal Patients Wed, 02 Jul 2008 15:14:02 GMT By measuring the activity of four genes in cancer cells, scientists at the Albert Einstein College of Medicine of Yeshiva University accurately predicted whether colorectal tumors are sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.Ontario to cover cost of expensive cancer treatment Wed, 02 Jul 2008 18:38:06 GMT Province adds $50 million to drug budgetRevised autism bill passes Legislature Thu, 03 Jul 2008 05:23:38 GMT It's been through many rewrites during the past week, but a bill mandating private insurance coverage of autism treatments forProvince funds three new cancer drugs Wed, 02 Jul 2008 19:39:44 GMT Some good news today for cancer patients, the Ontario government will now pay for three new and expensive cancer drugs. The province will spend 50 million dollars over the next three years for three drugs that until now cancer patients had to pay for themselves at private clinics.Ontario to cover costs of expensive cancer drugs Wed, 02 Jul 2008 15:52:31 GMT Updated: Wed Jul. 02 2008 11:34:35 AM The Canadian PressLow Use Of Medical Check-Ups For Intestinal Cancer Wed, 02 Jul 2008 10:12:32 GMT Only 20% of persons aged over 55 use colonoscopies for early detection of cancer, even though the statutory health insurance funds have covered the costs since 2002. This was shown by an analysis of the Bavarian Colonoscopy Database published in the current edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2008; 105(24): 434-40). http://www.aerzteblatt.de/v4/archiv/pdf.Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx) Thu, 03 Jul 2008 03:00:00 GMT Vista Partners announced today that it has updated coverage on leading Australian biotechnology company Arana Therapeutics, . "In our opinion, Arana differentiates itself from many competitors in the biotech space due to a strong cash position, a lucrative recurring revenue stream from IP licenses and a strong internal portfolio of products and proprietary technology platform. |
Infectious and parasitic diseases |
|
|
< Home > |
||